RecruitingNot ApplicableNCT06027242

Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy


Sponsor

National Taiwan University Hospital

Enrollment

120 participants

Start Date

Feb 21, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Glutamine has the potentials of immunomodulation and adjustment of protein metabolism. The primary objective of this study is to evaluate the efficacy of glutamine on sarcopenia in gastric adenocarcinoma patients undergoing gastrectomy. The secondary endpoints, including the physical activity, weight loss, and nutritional profiles, will be evaluated among these patients.


Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether taking glutamine supplements by mouth after stomach removal surgery (gastrectomy) for gastric cancer can help patients recover faster and reduce complications. Gastrectomy is a major surgery and the digestive system needs support to heal — glutamine is an amino acid important for gut repair. **You may be eligible if...** - You are an adult with gastric cancer who has recently undergone a gastrectomy (stomach removal surgery) **You may NOT be eligible if...** - You have liver failure or kidney failure - You cannot tolerate oral or tube feeding within 7 days after surgery - You cannot undergo a CT scan - You cannot wear the wearable monitoring devices used in the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENToral glutamine

10 g glutamine +5 g Maltodextrin for 28 days after surgery with tolerable oral intake or enteral feeding

DIETARY_SUPPLEMENTMaltodextrin

Maltodextrin


Locations(1)

National Taiwan University Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06027242


Related Trials